Biotest AG: Biotest AG opens fifth plasma collection centre in Hungary
News: Biotest AG / Key word(s): Miscellaneous / PRESS RELEASE Biotest AG opens fifth plasma collection centre in Hungary - Thirteen plasma collection centres in Europe and - Twenty in the US to ensure long-term plasma supply
The first plasma collection centre in Budapest was opened in 2009 by Plazmaszolgálat Kft., a 100% subsidiary of Biotest AG. "We are very pleased about the opening of another donor centre in Hungary. Our plasma collection organisation enables us to deliver highly ethical pharmaceutical products to the Hungarian market out of Hungarian plasma", stated Dr Martin Reinecke, Senior Vice President Plasma Alliances and Protein Supply of Biotest AG. The collected plasma is processed only by Biotest AG in Dreieich. By expanding its plasma collection capacity, the company is able to supply the Hungarian market with products exclusively from Hungarian plasma. Regular audits ensure that the strict legal and internal quality requirements are met. About human blood plasma About Biotest IR contact PR contact Biotest AG, Landsteinerstr. 5, 63303 Dreieich, www.biotest.de Ordinary shares: securities' ID No. 522720; ISIN DE0005227201 Disclaimer This document contains forward-looking statements on overall economic development as well as on the business, earnings, financial and assets position of Biotest AG and its subsidiaries. These statements are based on current plans, estimates, forecasts and expectations of the company and are thus subject to risks and elements of uncertainty that could result in significant deviation of actual developments from expected developments. The forward-looking statements are only valid at the time of publication. Biotest does not intend to update the forward-looking statements and assumes no obligation to do so. 2016-07-29 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English | |
Company: | Biotest AG | |
Landsteinerstraße 5 | ||
63303 Dreieich | ||
Germany | ||
Phone: | 0 61 03 - 8 01-0 | |
Fax: | 0 61 03 - 8 01-150 | |
E-mail: | investor_relations@biotest.de | |
Internet: | http://www.biotest.de | |
ISIN: | DE0005227235, DE0005227201 | |
WKN: | 522723, 522720 | |
Indices: | SDAX | |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange | |
End of News | DGAP News Service |